Agribusiness, Agriculture, Veterinary Medicine, Cassava, Garri, food security, Agritech and the Red Meat Value Chain.
Tuesday, May 23, 2017
Animal immunotherapy shows promise against 11 types of cancer.
Animal immunotherapy shows promise against 11 types of cancer. Veterinarian Mark Suckow pioneered a new veterinary cancer treatment called VetiVax, an injection series that primes an animal's immune system to fight cancer, and the $1,200 treatment has been used in over 150 animals, demonstrated initial response against 11 types of cancer and given 60% of patients longer life than expected.
"Immunotherapy is the future of cancer medicine, not only for animals but for humans as well," said Ashley Kalinauskas, CEO of Torigen Pharmaceuticals, the maker of VetiVax. source
Subscribe to:
Post Comments (Atom)
Agribusiness ideas.
Popular Posts
-
Five ways agriculture could benefit from artificial intelligence. Agriculture is the industry that accompanied the evolution of humanity ...
-
What to Know About Cat Vaccinations.Cats don’t actually have nine lives, so you need to do what you can to protect them. The key? is the ...
-
AGRIBUSINESS : CASSAVA VALUE CHAIN AND FOOD SECURITY. Cassava called Manihot esculenta, is extensively cultivated as an annual crop...
-
The vaccination protocol is not as cumbersome as for laying flock but are also essential as the market date is 42 days(6 weeks). ...
-
RESEARCH: Cassava root meal as substitute for maize in layers ration. The effect of replacing maize with graded levels of cassava root me...
-
Curcumin offers potential therapy for #cancers caused by HPV. Curcumin, an antioxidant found in the curry spice turmeric, has been fou...
AGRIBUSINESS EDUCATION.
Translate
I-CONNECT -AGRICULTURE
AGRIBUSINESS TIPS.
AGRIBUSINESS.
The Agriculture Daily
veterinarymedicineechbeebolanle-ojuri.blogspot.com Cassava: benefits of garri as a fermented food. Cassava processing involves fermentation which is a plus for gut health. The fermentation process removes the cyanogenic glucosides present in the fres...
No comments:
Post a Comment